+ Sunday, October 31, 2010
+ Monday, November 1, 2010
+ Tuesday, November 2, 2010
+ Wednesday, November 3, 2010
+ Thursday, November 4, 2010
Sunday, October 31, 2010
3:05 p.m - Ballroom A
Improving IMRT Planning with Automated Quality Control – The Washington University Experience
Kevin Moore
Washington University, USA
Monday, November 1, 2010
8:00 a.m. – 9:30 a.m. Room: Ballroom A
Transitioning from 3D IMRT to 4D IMRT and the Role of Image Guidance
Ping Xia, Ph.D., Cleveland Clinic, USA
Peter Balter, Ph.D., M.D. Anderson Cancer Center, USA
8:00 a.m. – 9:30 a.m.
Educational Session 202
Advanced Non Small Cell Lung Cancer/Small Cell Lung Cancer: Integrating Systemic and Local Therapies (CT, Targeting Agents, Post-op RT, Neoadjuvant Therapy)
Walter J. Curran, Jr., M.D., Emory University School of Medicine
Room: 30 A/B/C/D/E
After this session, attendees should be able to:
- Clarify the optimal integration of chemotherapy and radiation for patients with unresectable stage III non-small cell lung cancer.
- Identify the best research opportunities to test new treatment paradigms for patients with stage III non-small cell lung cancer.
- Describe the current and potential role of integrating surgery into the combined modality management of stage III non-s mall cell lung cancer.
8:00 a.m. – 9:30 a.m.
Educational Session 203
Difficult Cases in Breast Cancer
Jay R. Harris, M.D., FASTRO, Brigham & Women’s Hospital/Dana-Farber Cancer Institute
Thomas A. Buchholz, M.D., M.D. Anderson Cancer Center
Julia R. White, M.D., Medical College of Wisconsin
David R. Byrd, M.D., University of Washington
Hope S. Rugo, M.D., University of California, San Francisco
Room: 6 A
After this session, attendees should be able to:
- Identify clinical settings where RT is or isn’t indicated When dealing with difficult and evolving areas in breast cancer.
- Recognize clinical settings where systemic therapy is indicated.
- Recognize clinical settings where surgery is indicated.
8:00 a.m. – 9:30 a.m.
Educational Session 211
Transitioning from 3D IMRT to 4D IMRT and the Role of Image Guidance
Ping Xia, Ph.D., Cleveland Clinic
Peter Balter, Ph.D., M.D. Anderson Cancer Center
Room: Ballroom A
After this session, attendees should be able to:
- Review various currently available IGRT and 4DCT technologies.
- Discuss how these technologies can be used to improve dose delivery precision and accuracy, in particular with dynamically changing tumor volumes.
- Explain the challenges and strategies in clinical implementation of 4D-IMRT in three specific cancer sites.
11:00 a.m. – 12:30 p.m. Room: 1 A
Poster No. 1036 Probabilistic Refinement for Automatic Segmentation of the Head and Neck Structures
Arish Qazi, Princess Margaret Hospital,USA
4:00 p.m. – 5:30 p.m. Room: 6C/F
Improving Contouring and Segmentation
Kristy K. Brock, Ph.D., Princess Margaret Hospital, Canada
Steve B. Jiang, Ph.D., University of California San Diego, USA
Daniel Low, Ph.D., Washington University, USA
4:00 p.m. – 5:30 p.m.
Educational Session 215
Upcoming ASTRO Guidelines: A Focus on Palliative Care
Carol A. Hahn, M.D., Duke University Medical Center
Eric Lin Chang, M.D., M.D. Anderson Cancer Center
Stephen Thomas Lutz, M.D., Blanchard Valley Regional Cancer Center
Benjamin Movsas, M.D., Henry Ford Hospital
Room: 6 D/E
After this session, attendees should be able to:
- Understanding of levels of data supporting various modes of Radiotherapy for Bone Metastases, Brain Metastases and Palliative Lung Cancer.
- Update on literature reviews and expert opinion from ASTRO task panels working on Palliative Care Guidelines.
Tuesday, November 2, 2010
8:00 a.m. – 9:30 a.m.
Educational Session 306
Concurrent CT/RT and Post-Op Radiotherapy for Head and Neck Cancer
Nancy Lee, M.D., Memorial Sloan-Kettering Cancer Center
Matthew Fury, M.D., Memorial Sloan-Kettering Cancer Center
David G. Pfister, M.D., Memorial Sloan-Kettering Cancer Center
Room: 29 A/B/C/D
After this session, attendees should be able to:
- Discuss the evidence for using concurrent chemoradiotherapy in both the definitive as well as the post-operative setting.
- Compare whether altered fractionation plus concurrent chemotherapy is better than standard fractionation with the same chemotherapy regimen.
- Discuss toxicity associated with the use of concurrent chemoradiotherapy.
8:00 a.m. – 9:30 a.m.
Educational Session 311
Towards Defining “Best Practices” to Improve Clinical Care in Radiation Oncology
Robert Adams, RTT, C.M.D., UNC School of Medicine
James Alan Hayman, M.D., University of Michigan Health Systems
Lawrence B. Marks, M.D., University of North Carolina
Todd Pawlicki, Ph.D., University of California San Diego
Room: 5 A/B
8:00 a.m. – 9:30 a.m.
Radiation Therapy and Newer Agents
Mitchell Machtay, M.D., University Hospitals Case Medical Center/Case Western Reserve University
Room 4
After this session, attendees should be able to:
- Discuss the status of “best practice” guidelines for dosimetrists/physicists.
- Discuss the status of “best practice” guidelines for therapists.
- Discuss the status of “best practice” guidelines for physicians/nurses.
- Discuss the role of Chart Rounds in achieving these best practices.
Wednesday, November 3, 2010
11:20 a.m. Room: Ballroom A
An Adaptive Feedback-Driven Optimization Strategy to Minimize Radiation Induced Lung Toxicity (RILT) in High Dose Lung Radiotherapy
Martha Matuszak
William Beaumont, USA
11:00 a.m. – 12:30 p.m. Room: 1 A
Poster No.1096 Robustness and Treatment Plan Optimization for Oropharyngeal Cancer - Implications for Adaptive Therapy
James Balter
MD Anderson, US
Poster No.1097 Retreatment Composite Dose Planning Using a Deformable Image Registration Method
Matthew Palmer
MD Anderson, US
Poster No.1100 4D-CT Pulmonary Ventilation Image-guided Radiotherapy Planning Is Significantly Influenced by Deformable Image Registration Algorithms and Metrics
Tokihiro Yamamoto, No. 1100
Stanford University, US
Poster No.1103 Fully Automatic Model Based Liver Surface Segmentation
Karl Bzdusek,
Philips Healthcare, US
3:30 p.m. - 5:00 p.m. Ballroom A
Technical Aspects of SBRT for Lung Cancer
Indrin J. Chetty, Ph.D., Henry Ford Hospital and Health Centers
Sonja Dieterich, Ph.D., Stanford University Hospital
Timothy D. Solberg, Ph.D., University of Texas Southwestern Medical Center
Robert D. Timmerman, M.D., University of Texas Southwestern Medical Center
Thursday, November 4, 2010
8:00 a.m. - 9:30 a.m. Room: 30 A/B/C/D/E
IGRT: Implementation and Appropriate Margins
Di Yan, D.Sc., William Beaumont Hospital
Marcel van Herk, Ph.D., Netherlands Cancer Institute
8:00 a.m. - 9:30 a.m. Room: 29 A/B/C/D
Treatment Planning for Prostate Cancer: Imaging (US CT MR) Immobilization, Fields, Tumor and Normal Tissue Doses
Jeff M. Michalski, M.D., M.B.A., Washington University Medical Center
Mark K. Buyyounouski, M.D., M.S., Fox Chase Cancer Center
Cynthia Ménard, M.D., FRCPC, Princess Margaret Hospital University Health Network University of Toronto